Emesis Clinical Trial
Official title:
Prospective Randomized Trial Evaluating the Feeding Regimen After Pyloromyotomy.
The objective of this study is to scientifically evaluate the ability to discharge patients
based on feeding schedule comparing ad lib feeds to our current scheduled regimen.
The hypothesis is that patients may be able to be discharged sooner with ad lib feeds.
Hypertrophic pyloric stenosis is a common disease occurring in 2 per 1,000 live births1.
Pyloric stenosis is a hypertrophy of the pyloric muscle which prevents emptying of the
stomach leading to gastric outlet obstruction. The vomiting that ensues becomes projectile
and results in severe dehydration. Traditionally this has been repaired with the
pyloromyotomy via a transverse incision in the right upper quadrant. In the last decade the
investigators have started doing the same procedure laparoscopically. Most institutions
follow similar guidelines as to what constitutes a hypertrophic pyloric channel, initial
electrolyte management and resuscitation prior to surgery, as well as the pyloromyotomy
(either open or laparoscopically).
Historically patients were fed the day after surgery, then 6 hours, and currently the
investigators wait 2 hours after surgery to start feeds. The investigators go through a
protocol of 2 rounds of clear liquids, 2 rounds of half strength formula/breast milk then 2
rounds of full strength. Some centers have advocated ad lib feeds where babies go straight
to full strength as tolerated when awake from the operation.
Institutional variability is even further confounded by individual attending variability in
some instances. Recent articles in the past two decades still prove that no consensus has
been found. Some institutions profess that Ad Libitum feeding is both cost-effective as well
as safe, but very few institutions to our knowledge follow this mantra. Others demand that
no feeds should be started within 4 hours post surgery stating that the increased vomiting
associated with this early feeding regimen actually prolongs the time to full feeds due to
anxiety and discomfort. What has been shown is that no matter whether patients start 4 hours
post surgery or wait 18 hours the time to full feeds is the same. All of these studies are
hindered by the fact that they all have retrospective components to their design.
What has also been propagated in two recent retrospective reviews is the implementation of
clinical pathways as well as standardized feeding regimens. Both of these showed a decrease
in length of stay postoperatively as well as hospital costs.
At our institution a clinical pathway and feeding regimen has been implemented. The feeding
regimen contrary to some of the previously quoted papers starts at 2 hours with sequential
feeding increases. A prospectively acquired dataset at our institution has shown that emesis
is correlated to the degree of dehydration of the child prior to surgery even with all the
children being on the same clinical pathway.
What all of these studies show us is that as a profession, Pediatric Surgery does not have
the proper evidence to support any one post-op feeding regimen.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01913990 -
Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
|
Phase 4 | |
Terminated |
NCT00869310 -
Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis
|
Phase 3 | |
Terminated |
NCT00869973 -
Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
|
Phase 3 | |
Completed |
NCT04719286 -
MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy
|
N/A | |
Completed |
NCT01046240 -
Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03478605 -
Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
|
Phase 2 | |
Recruiting |
NCT04564144 -
Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers
|
Phase 1/Phase 2 | |
Terminated |
NCT01148264 -
Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
|
Phase 2 | |
Completed |
NCT00152867 -
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
|
Phase 3 | |
Completed |
NCT04182750 -
Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study
|
N/A | |
Completed |
NCT02980289 -
DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer.
|
||
Completed |
NCT02602080 -
Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia
|
||
Completed |
NCT04585841 -
The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
|
Phase 1 | |
Completed |
NCT01414478 -
High Protein Intake to Decrease Emesis and Promote Patient Satisfaction in Labor
|
N/A | |
Not yet recruiting |
NCT02407600 -
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
|
Phase 2 |